KR910014123A - 여기 아미노산 신경전달체의 길항 물질로서 유용한 폴리아민 - Google Patents
여기 아미노산 신경전달체의 길항 물질로서 유용한 폴리아민 Download PDFInfo
- Publication number
- KR910014123A KR910014123A KR1019900022585A KR900022585A KR910014123A KR 910014123 A KR910014123 A KR 910014123A KR 1019900022585 A KR1019900022585 A KR 1019900022585A KR 900022585 A KR900022585 A KR 900022585A KR 910014123 A KR910014123 A KR 910014123A
- Authority
- KR
- South Korea
- Prior art keywords
- amino acid
- pharmaceutically acceptable
- neurotransmitters
- cell
- acceptable salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polyamides (AREA)
- Indole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (7)
- 하기 일반식의 화합물로 이루어진 그룹중에서 선택된 거의 순수한 화합물 및 약제학적으로 허용되는 이의 염.상기식에서, R은 수소 또는 OH이다.
- 제1항에 있어서, R이 수소인 하기 일반식의 화합물 또는 약제학적으로 허용되는 이의 염.
- 제1항에 있어서, R이 OH인 하기 일반식의 화합물 또는 약제학적으로 허용되는 이의 염.
- 여기 아미노산 신경 전달체를 길항시키는 양의 제1항에 따른 화합물 또는 약제학적으로 허용되는 이의 염을 신경 전달체의 영향을 받는 세포에 투여함을 특징으로 하여 여기 아미노산 신경 전달체를 길항시키는 방법.
- 제4항에 있어서, 세포가 포유동물의 신경계내에 존재하는 세포인 방법.
- 제4항에 있어서, 세포가 무척추동물의 신경계내에 존재하는 세포인 방법.
- 여기 아미노산 신경 전달체를 길항시키는 양의 제1항에 따른 화합물 또는 약제학적으로 허용되는 이의 염 및 약제학적으로 허용되는 희석제 또는 담체를 포함하는 포유동물의 신경계내에 존재하는 세포에 영향을 미치는 아미노산 신경전달체를 길항시키기 위한 약제학적 조성물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46020790A | 1990-01-02 | 1990-01-02 | |
US460,207 | 1990-01-02 | ||
US460207 | 1990-01-02 | ||
US560699 | 1990-07-31 | ||
US560,699 | 1990-07-31 | ||
US07/560,699 US5037846A (en) | 1990-01-02 | 1990-07-31 | Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters |
Publications (2)
Publication Number | Publication Date |
---|---|
KR910014123A true KR910014123A (ko) | 1991-08-31 |
KR930007250B1 KR930007250B1 (ko) | 1993-08-04 |
Family
ID=27039601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900022585A KR930007250B1 (ko) | 1990-01-02 | 1990-12-31 | 여기 아미노산 신경전달체의 길항 물질로서 유용한 폴리아민 |
Country Status (23)
Country | Link |
---|---|
US (1) | US5037846A (ko) |
EP (1) | EP0436332B1 (ko) |
JP (1) | JPH0714913B2 (ko) |
KR (1) | KR930007250B1 (ko) |
CN (1) | CN1053059A (ko) |
AT (1) | ATE133941T1 (ko) |
AU (2) | AU619700B2 (ko) |
CA (1) | CA2033480C (ko) |
DE (1) | DE69025305T2 (ko) |
DK (1) | DK0436332T3 (ko) |
ES (1) | ES2083439T3 (ko) |
FI (1) | FI93644C (ko) |
GR (1) | GR3019487T3 (ko) |
HU (1) | HUT56063A (ko) |
IE (1) | IE70757B1 (ko) |
IL (1) | IL96793A0 (ko) |
MY (1) | MY104588A (ko) |
NO (1) | NO173733C (ko) |
NZ (1) | NZ236550A (ko) |
PH (1) | PH27608A (ko) |
PL (1) | PL165647B1 (ko) |
PT (1) | PT96389A (ko) |
YU (1) | YU247590A (ko) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5227397A (en) * | 1989-04-28 | 1993-07-13 | Pfizer Inc. | Polyamines and polypeptides useful as antagonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels |
US5037846A (en) * | 1990-01-02 | 1991-08-06 | Pfizer Inc. | Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters |
US5312928A (en) * | 1991-02-11 | 1994-05-17 | Cambridge Neuroscience | Calcium channel antagonists and methodology for their identification |
US5677288A (en) * | 1991-05-15 | 1997-10-14 | Cypros Pharmaceutical Corporation | Use of aminoglycosides to protect against excitotoxic neuron damage |
US5185369A (en) * | 1991-08-23 | 1993-02-09 | Pfizer Inc. | Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists |
CA2114798A1 (en) * | 1991-08-23 | 1993-03-04 | Nicholas A. Saccomano | Synthetic aryl polyamines as excitatory amino acid neurotransmitter antagonists |
US5763568A (en) * | 1992-01-31 | 1998-06-09 | Zeneca Limited | Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders |
US6071970A (en) * | 1993-02-08 | 2000-06-06 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
US6211245B1 (en) | 1993-02-08 | 2001-04-03 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
US7087765B2 (en) | 1995-06-07 | 2006-08-08 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
US6017965A (en) * | 1993-02-08 | 2000-01-25 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
US6750244B2 (en) | 1993-02-08 | 2004-06-15 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
RU2201224C2 (ru) | 1994-02-08 | 2003-03-27 | Эн-Пи-Эс Фармасьютикалз, Инк. | Соединения, активные в новом сайте на рецептор-регулируемых кальциевых каналах и используемые для лечения неврологических расстройств и заболеваний |
US5688764A (en) * | 1995-02-17 | 1997-11-18 | Nps Pharmaceuticals, Inc. | Insecticidal peptides from spider venom |
US5874298A (en) * | 1995-02-17 | 1999-02-23 | Nps Pharmaceuticals, Inc. | Insecticidal toxins from Bracon hebetor nucleic acid encoding said toxin and methods of use |
US5674846A (en) * | 1996-09-04 | 1997-10-07 | Nps Pharmaceuticals, Inc. | Insecticidal peptides from Segestria sp. spider venom |
WO1998036743A1 (en) * | 1997-02-21 | 1998-08-27 | Cypros Pharmaceutical Corporation | Neuroprotective poly-guanidino compounds which block presynaptic n and p/q calcium channels |
AU2003231670B2 (en) * | 1997-10-27 | 2006-06-08 | Slil Biomedical Corporation | Methods for modulating macrophage proliferation using polyamine analogs |
US8198334B2 (en) * | 1997-10-27 | 2012-06-12 | Pathologica Llc | Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
US7087648B1 (en) * | 1997-10-27 | 2006-08-08 | The Regents Of The University Of California | Methods for modulating macrophage proliferation using polyamine analogs |
WO2003043616A2 (en) * | 2001-11-16 | 2003-05-30 | Als Therapy Development Foundation, Inc. | Treatment of neurodegenerative disorders through the modulation of the polyamine pathway |
AU2002343609B2 (en) | 2001-11-16 | 2008-12-11 | Als Therapy Development Foundation, Inc. | Treatment of neurodegenerative disorders through the modulation of the polyamine pathway |
WO2006041805A1 (en) * | 2004-10-04 | 2006-04-20 | Cellgate, Inc. | Polyamine analogs as therapeutic agents for ocular diseases |
EP1937235B1 (en) * | 2005-09-23 | 2015-07-01 | Pathologica, LLC. | Methods for treating viral infections using polyamine analogs |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4925664A (en) * | 1986-10-20 | 1990-05-15 | University Of Utah | Spider toxins and methods for their use as blockers of calcium channels and amino acid receptor function |
IT1206078B (it) * | 1987-06-03 | 1989-04-14 | Polifarma Spa | Procedimento per la produzione di acido 3-indolpiruvico e suoi derivati loro uso farmaceutico |
US4950739A (en) * | 1988-02-10 | 1990-08-21 | New York University | Membrane calcium channels and factors and methods for blocking, isolating and purifying calcium channels |
DD298412A5 (de) * | 1989-04-28 | 1992-02-20 | ������@���Kk�� | Verfahren zur herstellung von polypeptiden, die geeignet sind als antagonisten exzitatorischer aminosaeure-neurotransmitter und/oder blocker der calciumkanaele |
US5037846A (en) * | 1990-01-02 | 1991-08-06 | Pfizer Inc. | Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters |
-
1990
- 1990-07-31 US US07/560,699 patent/US5037846A/en not_active Expired - Lifetime
- 1990-12-14 AT AT90313663T patent/ATE133941T1/de not_active IP Right Cessation
- 1990-12-14 DK DK90313663.8T patent/DK0436332T3/da active
- 1990-12-14 DE DE69025305T patent/DE69025305T2/de not_active Expired - Lifetime
- 1990-12-14 ES ES90313663T patent/ES2083439T3/es not_active Expired - Lifetime
- 1990-12-14 EP EP90313663A patent/EP0436332B1/en not_active Expired - Lifetime
- 1990-12-19 PH PH41752A patent/PH27608A/en unknown
- 1990-12-19 NZ NZ236550A patent/NZ236550A/en unknown
- 1990-12-26 IL IL96793A patent/IL96793A0/xx unknown
- 1990-12-27 PL PL90288490A patent/PL165647B1/pl unknown
- 1990-12-28 AU AU68561/90A patent/AU619700B2/en not_active Ceased
- 1990-12-28 NO NO905616A patent/NO173733C/no unknown
- 1990-12-28 PT PT96389A patent/PT96389A/pt not_active Application Discontinuation
- 1990-12-28 JP JP2418815A patent/JPH0714913B2/ja not_active Expired - Lifetime
- 1990-12-28 YU YU247590A patent/YU247590A/sh unknown
- 1990-12-29 MY MYPI90002301A patent/MY104588A/en unknown
- 1990-12-29 HU HU908509A patent/HUT56063A/hu unknown
- 1990-12-31 CN CN90110248A patent/CN1053059A/zh active Pending
- 1990-12-31 IE IE473490A patent/IE70757B1/en not_active IP Right Cessation
- 1990-12-31 CA CA002033480A patent/CA2033480C/en not_active Expired - Lifetime
- 1990-12-31 FI FI906466A patent/FI93644C/fi active IP Right Grant
- 1990-12-31 KR KR1019900022585A patent/KR930007250B1/ko not_active IP Right Cessation
-
1992
- 1992-04-30 AU AU15926/92A patent/AU640565B2/en not_active Ceased
-
1996
- 1996-04-02 GR GR960400875T patent/GR3019487T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR910014123A (ko) | 여기 아미노산 신경전달체의 길항 물질로서 유용한 폴리아민 | |
Cormier et al. | THE IDENTIFICATION OF KCF: REQUIREMENT OF LONG-CHAIN ALDEHYDES FOR BACTERIAL EXTRACT LUMINESCENCE1 | |
EP0168832A3 (en) | Pharmaceutical composition containing a tetrapyrrole compound as active ingredient and process for the production of the tetrapyrrole compound | |
SE8305299D0 (sv) | Tiaazaforeningar med -laktamer | |
DE68914292D1 (de) | Zusammensetzung zur Behandlung von ischämischen Störungen in Organen. | |
RU94028888A (ru) | Производные 1,3-замещенного циклоалкана и циклоалкена, смесь их изомеров или индивидуальные изомеры, их гидраты и соли, способ их получения и фармацевтическая композиция | |
EA200100533A1 (ru) | Производные эритромицина, способ их получения и их применение в качестве лекарственных средств | |
ATE61340T1 (de) | Aminosaeurederivate und deren verfahren zur herstellung. | |
BR1100061A (pt) | Composto, processo para a preparação do mesmo, composição e uso dos mesmos | |
EA200200108A1 (ru) | Производные стрептограминов, способ их получения и композиции на их основе | |
KR890009845A (ko) | 아릴옥시페닐 프로필아민, 이의 제조방법 및 용도 | |
ES8706833A1 (es) | Un procedimiento para preparar un aminoacido opticamente activo | |
OA08835A (fr) | Nouveaux dérivés de la 1,2,5,6-tétrahydropyridine, leur procédé de préparation, leur application comme médicaments et les compositions les renfermant. | |
IL75116A (en) | Ethyl substituted-beta-carboxylates,process for the preparation thereof and pharmaceutical compositions containing the same | |
KR890001965A (ko) | 스퍼구알린 관련 유도체 | |
FI963440A (fi) | Uudet aminohappojohdannaiset, näiden valmistusmenetelmä ja näitä yhdisteitä sisältävät farmaseuttiset seokset | |
DE3673468D1 (de) | N-alkyl-2,6-dimethylmorpholinio-carbonsaeureamid-salze, verfahren zu ihrer herstellung und ihre verwendung als fungizide. | |
TR200002808T2 (tr) | İlaç olarak yararlı C11 oksimil ve hidroksilamino prostaglandinleri | |
PE41896A1 (es) | Antagonista del receptor de aminoacido excitativo | |
DE69300453D1 (de) | Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen. | |
EA200500716A1 (ru) | Новые соединения 2,3-дигидро-4-(1h)-пиридона, способ их получения и фармацевтические композиции, которые их содержат | |
ATE20588T1 (de) | Heterozyklische verbindungen geeignet als pestizide und verfahren zu ihrer herstellung. | |
ES8406452A1 (es) | Procedimiento para la obtencion de nuevos derivados de benzazol. | |
KR910004632A (ko) | 신규한 1-옥사-2-옥소-8-아자스피로[4,5]데칸 유도체와 그들을 포함하는 약제학적 조성물 및 그 제조방법 | |
SE7910430L (sv) | Cyklododekanderivat jemte sett for deras framstellning |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |